Reliable synthetic peptide substances for academic research trials, steady composition, multiple packing choices
2 Inquiries
320367-13-3
Research Grade
99%
qingdao
Peptide
5mg;10mg;15mg;20mg;30mg;40mg;50mg;100mg;500mg
2027-01-31
Cosmetics
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceLixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). Sequence: His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2.Basic Info
-
Product Name:
Lixisenatide
Other Name:lixisenatide;Lixisenatide|Lixisenatide Acetate;Lixisenatide Acetate
CAS No.:320367-13-3
Molecular Formula:C215H347N61O65S
InChIKeys:XVVOERDUTLJJHN-IAEQDCLQSA-N
Molecular Weight:4858.53
Exact Mass:4855.54000
Categories:
Characteristics-
PSA:
2090
XLogP3:2.13170
Research-
Class:
GLP-1 receptor agonist (exendin-4 derivative, 44-amino-acid peptide)
Status:FDA-approved (Adlyxin 2016) / EU-approved (Lyxumia 2013)
Mechanism:A 44-amino-acid peptide derived from exendin-4 with C-terminal modification (6 Lys residues added). Acts as a GLP-1 receptor agonist with prolonged half-life (~3 hours). Enhances glucose-dependent insulin secretion, suppresses glucagon, and slows gastric emptying.
EC50 (GLP1R Ic50):1.4 nM
Source:DrugBank: DB09343; AbMole product data sheet.
Clinical Development:FDA:Adlyxin (approved 2016-07-28)
References-
ChEMBL:
CHEMBL2108674
DrugBank:PubChem:Literature:Disclaimer:Lixisenatide is FDA-approved as a prescription medicine (Adlyxin) for type 2 diabetes. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
Serious eye damage, Category 1
Reproductive toxicity, Category 2
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Danger
Hazard statement(s) H318 Causes serious eye damage
H361 Suspected of damaging fertility or the unborn child
Precautionary statement(s) Prevention P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P203 Obtain, read and follow all safety instructions before use.
Response P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P317 Get medical help.
P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Cosmetics
-
Location:
Room 204, Unit 1, Building 3, Liming 1st District, Choujiang Subdistrict, Wenwu City, Jinhua City, China (Zhejiang) Pilot Free Trade Zone
-
Year of Establishment:
2026
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted
Germany
Lixisenatide
1 PCS Sep 30, 2026
United Arab Emirates
Lixisenatide
5 G Oct 24, 2025 Post an enquiry for this product
More from this Seller
-
-
-
Klow Peptide Lyophilized Powder 10mg 15mg 20mg 30mg 40mg 50mg Laboratory Research Peptide
Pharmaceutical Grade / 99%
-
-
-
-
EPI Epitalon Research Peptide High Purity Lyophilized Powder For Laboratory Research Only
Research Grade / 99%
$8/UNIT EXW
-
-
-
-
Consistent peptide supply, 99% purity adjustable sealed vial packaging types
Research Grade / 99%
-
-
-
-
DSIP peptide powder packed in airtight glass vials
Research Grade / 99%
$50/UNIT EXW
-
-
-
-
SURVODUTIDE freeze dried peptide, consistent powder condition in large production
Research Grade / 99%
$195/UNIT EXW
-
-
-
-
Peptide powder friendly for reconstitution, works well with common sterile solvent
Research Grade / 99%
$10/UNIT EXW
-